NCT00459342 2019-03-05Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Completed35 enrolled 12 charts
NCT00470054 2015-05-05Dasatinib in Treating Patients With Relapsed Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Completed44 enrolled 10 charts